Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, engineering, and reinfusing a patient’s immune cells. Using a two-particle delivery system, the researchers sent CRISPR gene-editing tools and new cancer-targeting DNA specifically into T cells, where the DNA was inserted at a precise location in the genome.
Scientists Develop In-Body Method to Create Cancer-Fighting CAR-T Cells
Scientists at UC San Francisco have developed a method to create cancer-fighting CAR-T cells directly in the body, potentially streamlining the treatment process. This innovation could significantly reduce costs and improve accessibility to advanced cancer therapies. While not directly related to Iran, advancements in medical technology can influence healthcare policies and research collaborations in the region.
👥 Key Players
📰 What Happened
Scientists at UC San Francisco have created a method to generate CAR-T cells within the body, which could streamline cancer treatment and reduce costs. This innovation uses CRISPR technology to directly edit T cells for cancer targeting.
- The method uses a two-particle delivery system for gene editing.
- It aims to eliminate the need for complex cell extraction and reinfusion processes.
💡 Why It Matters
📚 Background
CAR-T cell therapy is a groundbreaking cancer treatment that modifies a patient's immune cells to fight cancer. The traditional process is costly and complex, making it less accessible.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%